Our analysis indicated that the level of SLC10A3 is correlated with CRC malignancy in tumor relapse and metastasis (Fig. 9E–F), but not in lymph node invasion status and tumor stage (Fig. S2AB). Here, SLC10A3 is linked to neoplasm.